Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
-
Published:2018-07
Issue:
Volume:
Page:
-
ISSN:1079-9796
-
Container-title:Blood Cells, Molecules, and Diseases
-
language:
-
Short-container-title:
您需要登录后可以查看相关数据！